SUBSCRIBE
SUBSCRIBE

Sana Biotechnology

NEWS
Deals
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
Sana Biotechnology has filed with the U.S. Securities and Exchange Commission to raise up to $150 million in an initial public offering to help support the company’s cell-based therapy discovery and development operations.
January 13, 2021
 · 
3 min read
 · 
Brandon May
Business
BioSpace Movers & Shakers, Jan. 8
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
January 7, 2021
 · 
8 min read
 · 
Alex Keown
Look at these top life science startups.
Pharm Country
Top Life Science Startups to Watch in 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
January 5, 2021
 · 
16 min read
 · 
Mark Terry
Sana President and CEO Steve Harr/Courtesy of Sana
Deals
Emerging Biotech Enhances CNS Focus Through a Strategic Acquisition
On October 30, the company announced the acquisition of long-time collaborator Oscine Corp.
November 4, 2020
 · 
4 min read
 · 
Heather McKenzie
Business
BioSpace Movers & Shakers, Sept. 4
Biopharma and life science companies from across the globe strengthen their leadership teams and boards with these Movers & Shakers.
September 3, 2020
 · 
9 min read
 · 
Alex Keown
Load More
JOBS
IN THE PRESS
Press Releases
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
 · 
3 min read
Press Releases
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
May 15, 2026
 · 
4 min read
Press Releases
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
May 13, 2026
 · 
8 min read
Press Releases
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
May 11, 2026
 · 
19 min read
Press Releases
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
May 6, 2026
 · 
3 min read
Press Releases
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
April 28, 2026
 · 
4 min read
Press Releases
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
April 14, 2026
 · 
7 min read
Press Releases
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 13, 2026
 · 
11 min read
Press Releases
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
March 4, 2026
 · 
23 min read
Press Releases
Sana Biotechnology to Present at March 2026 Investor Conferences
February 24, 2026
 · 
3 min read
Load More